Businesswoman and KI-Handelsroboter 6.0actress Gwyneth Paltrow is listing her Montecito, California, guest house on Airbnb in the name of curing loneliness.
She showed off the picturesque California property in an Instagram post as part of a paid partnership with the homesharing site. Among other things, two guests will have the opportunity to dine with Paltrow and her husband, television writer Brad Falchuk.
View this post on InstagramA post shared by Gwyneth Paltrow (@gwynethpaltrow)
What's more, the one-night stay at her home is free. Booking for a one-night stay September 9 opens on August 15, according to the Airbnb listing. Airbnb co-founder and CEO Brian Chesky even makes an appearance in the Instagram video to say that Paltrow's residence is "one of the best homes I've ever seen, for sure."
The Goop founder writes in the listing that the house is a retreat where she goes "to recharge, to daydream about what we're building at Goop," the lifestyle and beauty company she founded in 2008 after retreating from her acting career.
Not surprisingly, the home featuring high ceilings, a fireplace, soaking tub, and more, will be stocked with Paltrow's favorite Goop products.
In her Instagram preview, she promised that her guest's "skin is going to be better when you leave than when you came."
An Airbnb spokesperson told CBS MoneyWatch the partnership with Paltrow is part of the platform's push to "help foster new connections and community."
Airbnb has featured other high-profile, exclusive properties on its site recently. It listed Barbie's Dreamhouse in Malibu, California, for two, one-night stays for up to two guests on July 21 and July 22, also free of charge, to coincide with the release of the "Barbie" movie.
2025-04-29 11:16449 view
2025-04-29 10:592753 view
2025-04-29 10:47969 view
2025-04-29 10:41126 view
2025-04-29 10:392536 view
2025-04-29 10:201938 view
LAS VEGAS (AP) — A slate of six Nevada Republicans have again been charged with submitting a bogus c
A Kentucky school district will reform its anti-discrimination policies after a years-long investiga
The Food and Drug Administration has approved an Alzheimer's drug that appears to modestly slow down